Inhibrx Biosciences, Inc. (INBX)
Nasdaq: INBX · CIK 0002007919 · United States
Every official Inhibrx Biosciences, Inc. filing in one place: annual reports, quarterly results, current reports,
proxy statements, shareholding and announcements, straight from the regulator. Free to search.
Open INBX filings
Inhibrx Biosciences, Inc. documents
- Inhibrx Biosciences, Inc. 10-K 2026INBX 10-K 2026: annual report for fiscal 2026
- Inhibrx Biosciences, Inc. 10-K 2025INBX 10-K 2025: annual report for fiscal 2025
- Inhibrx Biosciences, Inc. 10-K 2024INBX 10-K 2024: annual report for fiscal 2024
- Inhibrx Biosciences, Inc. 10-K 2023INBX 10-K 2023: annual report for fiscal 2023
- Inhibrx Biosciences, Inc. 10-K 2022INBX 10-K 2022: annual report for fiscal 2022
- Inhibrx Biosciences, Inc. 10-Q 2026INBX 10-Q 2026: quarterly report for fiscal 2026
- Inhibrx Biosciences, Inc. 10-Q 2025INBX 10-Q 2025: quarterly report for fiscal 2025
- Inhibrx Biosciences, Inc. 10-Q 2024INBX 10-Q 2024: quarterly report for fiscal 2024
- Inhibrx Biosciences, Inc. 10-Q 2023INBX 10-Q 2023: quarterly report for fiscal 2023
- Inhibrx Biosciences, Inc. 10-Q 2022INBX 10-Q 2022: quarterly report for fiscal 2022
- Inhibrx Biosciences, Inc. 8-K 2026INBX 8-K 2026: current report for fiscal 2026
- Inhibrx Biosciences, Inc. 8-K 2025INBX 8-K 2025: current report for fiscal 2025
- Inhibrx Biosciences, Inc. 8-K 2024INBX 8-K 2024: current report for fiscal 2024
- Inhibrx Biosciences, Inc. 8-K 2023INBX 8-K 2023: current report for fiscal 2023
- Inhibrx Biosciences, Inc. 8-K 2022INBX 8-K 2022: current report for fiscal 2022
- Inhibrx Biosciences, Inc. DEF 14A 2026INBX DEF 14A 2026: proxy statement for fiscal 2026
- Inhibrx Biosciences, Inc. DEF 14A 2025INBX DEF 14A 2025: proxy statement for fiscal 2025
- Inhibrx Biosciences, Inc. DEF 14A 2024INBX DEF 14A 2024: proxy statement for fiscal 2024
- Inhibrx Biosciences, Inc. DEF 14A 2023INBX DEF 14A 2023: proxy statement for fiscal 2023
- Inhibrx Biosciences, Inc. DEF 14A 2022INBX DEF 14A 2022: proxy statement for fiscal 2022
- Inhibrx Biosciences, Inc. Form 4 2026INBX Form 4 2026: insider trading filing for fiscal 2026
- Inhibrx Biosciences, Inc. Form 4 2025INBX Form 4 2025: insider trading filing for fiscal 2025
- Inhibrx Biosciences, Inc. Form 4 2024INBX Form 4 2024: insider trading filing for fiscal 2024
- Inhibrx Biosciences, Inc. Form 4 2023INBX Form 4 2023: insider trading filing for fiscal 2023
- Inhibrx Biosciences, Inc. Form 4 2022INBX Form 4 2022: insider trading filing for fiscal 2022
- Inhibrx Biosciences, Inc. S-1 2026INBX S-1 2026: registration statement for fiscal 2026
- Inhibrx Biosciences, Inc. S-1 2025INBX S-1 2025: registration statement for fiscal 2025
- Inhibrx Biosciences, Inc. S-1 2024INBX S-1 2024: registration statement for fiscal 2024
- Inhibrx Biosciences, Inc. S-1 2023INBX S-1 2023: registration statement for fiscal 2023
- Inhibrx Biosciences, Inc. S-1 2022INBX S-1 2022: registration statement for fiscal 2022
- Inhibrx Biosciences, Inc. 13F 2026INBX 13F 2026: institutional holdings for fiscal 2026
- Inhibrx Biosciences, Inc. 13F 2025INBX 13F 2025: institutional holdings for fiscal 2025
- Inhibrx Biosciences, Inc. 13F 2024INBX 13F 2024: institutional holdings for fiscal 2024
- Inhibrx Biosciences, Inc. 13F 2023INBX 13F 2023: institutional holdings for fiscal 2023
- Inhibrx Biosciences, Inc. 13F 2022INBX 13F 2022: institutional holdings for fiscal 2022
More companies